Puma Biotechnology Inc

PBYINASDAQ · USD
9.93USD+0.15 (+1.54%)
8110

Puma Biotechnology Inc (PBYI) Historical Volatility

PBYI 30-day historical volatility is 40%. This ranks in the 29th percentile of readings over the past year.

Read more

Tracking PBYI historical volatility helps you see how much Puma Biotechnology Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Puma Biotechnology Inc's HV tells you what really happened. Use our scanner to monitor PBYI 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.

Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The PBYI 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Puma Biotechnology Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd.

The company was founded in 2010 and is headquartered in Los Angeles, California.

Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Puma Biotechnology Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where PBYI HV is running hot, cold, or in line. Make the PBYI 30 day historical volatility — and every other window — work for your edge instead of against it.

IV vs HV
Implied Volatility (IV) vs Historical Volatility (HV) over the past month.

As of September 29, 2026

IV - HV Difference
Difference between IV and HV over time. Positive values indicate IV > HV.

As of September 29, 2026

See how volatility has moved over time

Track PBYI historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.

Start your 14-day free trial